Recent GDRX News
- GoodRx Interim CEO Extends Commitment to Company • Business Wire • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:15:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:20:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:00:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 07:37:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 07:04:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:12:19 AM
- GoodRx Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/29/2024 11:02:00 AM
- GoodRx to Participate in Upcoming Investor Conferences • Business Wire • 02/20/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:54:55 PM
- GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • Business Wire • 02/01/2024 09:05:00 PM
- GoodRx Announces Proposed Refinancing of First Lien Credit Facilities • Business Wire • 01/22/2024 07:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 08:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:00:56 PM
- The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings • Business Wire • 01/11/2024 02:00:00 PM
- GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024 • Business Wire • 01/10/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 02:06:27 PM
- GoodRx Appoints Kelly J. Kennedy to Board of Directors • Business Wire • 12/22/2023 02:00:00 PM
- GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/13/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:20:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:18:57 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM